Catherine Avery Investment Management’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.16M Sell
28,378
-14,190
-33% -$2.57M 1.82% 32
2026
Q1
$6.26M Buy
42,568
+20,190
+90% +$3.28M 2.8% 16
2025
Q4
$4.36M Buy
22,378
+4,139
+23% +$985K 2.61% 19
2025
Q3
$5.13M Sell
18,239
-1,338
-7% -$341K 3.3% 5
2025
Q2
$4.28M Buy
19,577
+1,044
+6% +$169K 3.25% 7
2025
Q1
$2.59M Sell
18,533
-562
-3% -$91.5K 2.32% 22
2024
Q4
$3.18M Buy
+19,095
New +$3.39M 2.81% 13

Other funds holding ORCL

Catherine Avery Investment Management's ORCL Position: Q2 2026 in Review

Catherine Avery Investment Management reduced its Oracle (ORCL) stake by 33% in Q2 2026, selling an estimated $2.57M and leaving 28,378 shares worth $4.16M. The position accounts for 1.82% of the portfolio, ranked #32.

Catherine Avery Investment Management first reported a position in ORCL in Q4 2024 and has held it in 7 quarters since. The position peaked at $6.26M in Q1 2026. 3,507 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Catherine Avery Investment Management held 28,378 shares of Oracle worth $4.16M as of Q2 2026.
  • Catherine Avery Investment Management sold 14,190 Oracle shares in Q2 2026, an estimated $2.57M.
  • Oracle made up 1.82% of Catherine Avery Investment Management's portfolio in Q2 2026, its #32 holding.
  • Catherine Avery Investment Management first reported a position in Oracle in Q4 2024 and has held it in 7 quarters since.
  • Catherine Avery Investment Management's Oracle position peaked at $6.26M in Q1 2026.
  • 3,507 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Catherine Avery Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.